Related references
Note: Only part of the references are listed.Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic-Resistant Gram-Negative Bacteria
Patrick D. Mauldin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Prevalence, Resistance Mechanisms, and Susceptibility of Multidrug-Resistant Bloodstream Isolates of Pseudomonas aeruginosa
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Reduced expression of virulence factors in multidrug-resistant Pseudomonas aeruginosa strains
Aleksander Deptula et al.
ARCHIVES OF MICROBIOLOGY (2010)
Imipenem Resistance in Pseudomonas aeruginosa: Emergence, Epidemiology, and Impact on Clinical and Economic Outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug-Resistant Bacteria in a Murine Pneumonia Model
Zhe Yuan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Initiation of Inappropriate Antimicrobial Therapy Results in a Fivefold Reduction of Survival in Human Septic Shock
Anand Kumar et al.
CHEST (2009)
Hospital and Societal Costs of Antimicrobial-Resistant Infections in a Chicago Teaching Hospital: Implications for Antibiotic Stewardship
Rebecca R. Roberts et al.
CLINICAL INFECTIOUS DISEASES (2009)
Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
Joshua D. Hartzell et al.
CLINICAL INFECTIOUS DISEASES (2009)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Initial Low-Dose Gentamicin for Staphylococcus aureus Bacteremia and Endocarditis Is Nephrotoxic
Sara E. Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2009)
Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia
Vincent H. Tam et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2009)
Efflux-Mediated Drug Resistance in Bacteria An Update
Xian-Zhi Li et al.
DRUGS (2009)
Combination Antimicrobial Treatment Versus Monotherapy: The Contribution of Meta-analyses
Mical Paul et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2009)
Clinical characteristics and risk factors of colistin-induced nephrotoxicity
Jieun Kim et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Nomenclature of plasmid-mediated 16S rRNA methylases responsible for panaminoglycoside resistance
Yohei Doi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Broad-spectrum antimicrobials and the treatment of serious bacterial infections: Getting it right up front
Marin H. Kollef
CLINICAL INFECTIOUS DISEASES (2008)
Pseudomonas aeruginosa serious infections:: Mono or combination antimicrobial therapy?
Matteo Bassetti et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Polymyxin B: a new strategy for multidrug-resistant Gram-negative organisms
Zhe Yuan et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Alexandre Prehn Zavascki et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections:: Impact of delayed appropriate antibiotic selection
Thomas P. Lodise et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Carbapenemases:: the versatile β-lactamases
Anne Marie Queenan et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
16S ribosomal RNA methylation: Emerging resistance mechanism against aminoglycosides
Yohei Doi et al.
CLINICAL INFECTIOUS DISEASES (2007)
Prevalence of AmpC over-expression in bloodstream isolates of Pseudomonas aeruginosa
V. H. Tam et al.
CLINICAL MICROBIOLOGY AND INFECTION (2007)
Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia
Regina B. Osih et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Cost of Gram-negative resistance
Heather L. Evans et al.
CRITICAL CARE MEDICINE (2007)
The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa
Matthew E. Falagas et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Benefit of appropriate empirical antibiotic treatment: Thirty-day mortality and duration of hospital stay
Abigail Fraser et al.
AMERICAN JOURNAL OF MEDICINE (2006)
The biological cost of mutational antibiotic resistance: any practical conclusions?
Dan I. Andersson
CURRENT OPINION IN MICROBIOLOGY (2006)
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
Robert A. Bonomo et al.
CLINICAL INFECTIOUS DISEASES (2006)
Imipenem resistance among Pseudomonas aeruginosa isolates:: Risk factors for infection and impact of resistance on clinical and economic outcomes
Ebbing Lautenbach et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2006)
Fluoroquinolone-resistant Pseudomonas aeruginosa:: Assessment of risk factors and clinical impact
Leanne B. Gasink et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock
Arland Kumar et al.
CRITICAL CARE MEDICINE (2006)
Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae
MJ Schwaber et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi
D Criswell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact
V Aloush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections
Jian Li et al.
LANCET INFECTIOUS DISEASES (2006)
Systematic review of economic analyses of health care-associated infections
PW Stone et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2005)
Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region:: Importance of metallo-β-lactamase (MBL)-producing strains
KB Laupland et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Overview of nosocomial infections caused by gram-negative bacilli
R Gaynes et al.
CLINICAL INFECTIOUS DISEASES (2005)
Survivability of vancomycin resistant enterococci and fitness cost of vancomycin resistance acquisition
AA Ramadhan et al.
JOURNAL OF CLINICAL PATHOLOGY (2005)
Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer
N Ohmagari et al.
CANCER (2005)
Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548
A Galimand et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Pseudomonas aeruginosa bloodstream infection:: Importance of appropriate initial antimicrobial treatment
ST Micek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units:: Role of antibiotics with antipseudomonal activity
E Paramythiotou et al.
CLINICAL INFECTIOUS DISEASES (2004)
Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis
N Safdar et al.
LANCET INFECTIOUS DISEASES (2004)
National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002
MD Obritsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Efflux-mediated multiresistance in Gram-negative bacteria
K Poole
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Efflux-mediated drug resistance in bacteria
XZ Li et al.
DRUGS (2004)
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004
D Cardo et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2004)
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections
B Cao et al.
JOURNAL OF HOSPITAL INFECTION (2004)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia
E Chamot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Clinical and bacteriological characteristics of IMP-type metallo-β-lactamase-producing Pseudomonas aeruginosa
Y Hirakata et al.
CLINICAL INFECTIOUS DISEASES (2003)
The impact of antimicrobial resistance on health and economic outcomes
SE Cosgrove et al.
CLINICAL INFECTIOUS DISEASES (2003)
Antibiotic resistance among gram-negative bacilli in US intensive care units - Implications for fluoroquinolone use
MM Neuhauser et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Fitness of in vitro selected Pseudomonas aeruginosa nalB and nfxB multidrug resistant mutants
P Sánchez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species
SE Cosgrove et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
DM Livermore
CLINICAL INFECTIOUS DISEASES (2002)
Characterization of Pseudomonas aeruginosa isolates:: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999
AC Gales et al.
CLINICAL INFECTIOUS DISEASES (2001)
Influence of the MexA-MexB-OprM multidrug efflux system on expression of the MexC-MexD-OprJ and MexE-MexF-OprN multidrug efflux systems in Pseudomonas aeruginosa
XZ Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
Aminoglycosides: Perspectives on mechanisms of action and resistance and strategies to counter resistance
LP Kotra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer -: Retrospective analysis of 245 episodes
I Chatzinikolaou et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
S Jalal et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
